These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 37002158)

  • 1. Corrigendum to "Discovery of lead natural products for developing pan-SARS-CoV-2 therapeutics" "Antiviral Research 209 (2023)/105484".
    Perez-Vargas J; Shapira T; Olmstead AD; Villanueva I; Thompson CAH; Ennis S; Gao G; De Guzman J; Williams DE; Wang M; Chin A; Bautista-Sanchez D; Agafitei O; Levett P; Xie X; Nuzzo G; Freire VF; Quintana-Bulla JI; Bernardi DI; Gubiani JR; Suthiphasilp V; Raksat A; Meesakul P; Polbuppha I; Cheenpracha S; Jaidee W; Kanokmedhakul K; Yenjai C; Chaiyosang B; Teles HL; Manzo E; Fontana A; Leduc R; Boudreault PL; Berlinck RGS; Laphookhieo S; Kanokmedhakul S; Tietjen I; Cherkasov A; Krajden M; Nabi IR; Niikura M; Shi PY; Andersen RJ; Jean F
    Antiviral Res; 2023 May; 213():105577. PubMed ID: 37002158
    [No Abstract]   [Full Text] [Related]  

  • 2. Microbial Natural Products with Antiviral Activities, Including Anti-SARS-CoV-2: A Review.
    Frediansyah A; Sofyantoro F; Alhumaid S; Al Mutair A; Albayat H; Altaweil HI; Al-Afghani HM; AlRamadhan AA; AlGhazal MR; Turkistani SA; Abuzaid AA; Rabaan AA
    Molecules; 2022 Jul; 27(13):. PubMed ID: 35807550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Target-Specific Drug Discovery of Natural Products against SARS-CoV-2 Life Cycle and Cytokine Storm in COVID-19.
    Lee M; Park J; Cho IH
    Am J Chin Med; 2022; 50(4):927-959. PubMed ID: 35729089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural Products as Potential Agents against SARS-CoV and SARSCoV- 2.
    Raimundo E Silva JP; Acevedo CAH; de Souza TA; de Menezes RPB; Sessions ZL; Abreu LS; Cibulski SP; Scotti L; da Silva MS; Muratov EN; Scotti MT; Tavares JF
    Curr Med Chem; 2021; 28(27):5498-5526. PubMed ID: 33550959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The discovery of herbal drugs and natural compounds as inhibitors of SARS-CoV-2 infection in vitro.
    Ngwe Tun MM; Toume K; Luvai E; Nwe KM; Mizukami S; Hirayama K; Komatsu K; Morita K
    J Nat Med; 2022 Mar; 76(2):402-409. PubMed ID: 35006524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Silico and In Vitro Identification of Pan-Coronaviral Main Protease Inhibitors from a Large Natural Product Library.
    Shahhamzehei N; Abdelfatah S; Efferth T
    Pharmaceuticals (Basel); 2022 Mar; 15(3):. PubMed ID: 35337106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a screening platform to discover natural products active against SARS-CoV-2 infection using lung organoid models.
    Lee JE; Jeong SY; Li Z; Kim HY; Kim HW; Yoo MJ; Jang HJ; Kim DK; Cho N; Yoo HM; Kim KH
    Biomater Res; 2023 Mar; 27(1):18. PubMed ID: 36855173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural Products with Tandem Anti-inflammatory, Immunomodulatory and Anti-SARS-CoV/2 Effects: A Drug Discovery Perspective against SARS-CoV-2.
    da Cunha LNOL; Tizziani T; Souza GB; Moreira MA; Neto JSS; Dos Santos CVD; de Carvalho MG; Dalmarco EM; Turqueti LB; Scotti MT; Scotti L; de Assis FF; Braga AL; Sandjo LP
    Curr Med Chem; 2022; 29(14):2530-2564. PubMed ID: 34313197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of 3-phenyl-1,2,4-oxadiazole derivatives as a new class of SARS-CoV-2 main protease inhibitors.
    Guo N; Huang C; Qiao J; Li Y; Wang Y; Xia A; Zhang G; Fang Z; You J; Li L
    Bioorg Med Chem Lett; 2023 Apr; 86():129238. PubMed ID: 36924946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of natural products to block SARS-CoV-2 S-protein interaction with Neuropilin-1 receptor: A molecular dynamics simulation approach.
    Alshawaf E; Hammad MM; Marafie SK; Ali H; Al-Mulla F; Abubaker J; Mohammad A
    Microb Pathog; 2022 Sep; 170():105701. PubMed ID: 35963279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Broad-spectrum coronavirus antiviral drug discovery.
    Totura AL; Bavari S
    Expert Opin Drug Discov; 2019 Apr; 14(4):397-412. PubMed ID: 30849247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening S protein - ACE2 blockers from natural products: Strategies and advances in the discovery of potential inhibitors of COVID-19.
    Ma LL; Liu HM; Liu XM; Yuan XY; Xu C; Wang F; Lin JZ; Xu RC; Zhang DK
    Eur J Med Chem; 2021 Dec; 226():113857. PubMed ID: 34628234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cotton flower metabolites inhibit SARS-CoV-2 main protease.
    Zhang Y; Li W; Hu Y; Ding T; Zafar MM; Jia X; Zhang L; Ren M; Li F; Wang W
    FEBS Open Bio; 2022 Oct; 12(10):1886-1895. PubMed ID: 36054247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural Flavonoid Derivatives Have Pan-Coronavirus Antiviral Activity.
    Mori M; Quaglio D; Calcaterra A; Ghirga F; Sorrentino L; Cammarone S; Fracella M; D'Auria A; Frasca F; Criscuolo E; Clementi N; Mancini N; Botta B; Antonelli G; Pierangeli A; Scagnolari C
    Microorganisms; 2023 Jan; 11(2):. PubMed ID: 36838279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-Pyridone natural products as inhibitors of SARS-CoV-2 main protease.
    Forrestall KL; Burley DE; Cash MK; Pottie IR; Darvesh S
    Chem Biol Interact; 2021 Feb; 335():109348. PubMed ID: 33278462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Harnessing Natural Products by a Pharmacophore-Oriented Semisynthesis Approach for the Discovery of Potential Anti-SARS-CoV-2 Agents.
    Zhou YF; Yan BC; Yang Q; Long XY; Zhang DQ; Luo RH; Wang HY; Sun HD; Xue XS; Zheng YT; Puno PT
    Angew Chem Int Ed Engl; 2022 Jul; 61(28):e202201684. PubMed ID: 35484726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL
    Froggatt HM; Heaton BE; Heaton NS
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32843534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Development in Small Molecules for SARS-CoV-2 and the Opportunity for Fragment-Based Drug Discovery.
    Mahato S
    Med Chem; 2022; 18(8):847-858. PubMed ID: 35156586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioactive Terpenes and Their Derivatives as Potential SARS-CoV-2 Proteases Inhibitors from Molecular Modeling Studies.
    Diniz LRL; Perez-Castillo Y; Elshabrawy HA; Filho CDSMB; de Sousa DP
    Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33430299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.